TRIP-tuh-fan

Therapeutic Classification: sedative/hypnotics, antidepressants

• Premenstrual dysphoric disorder (PMDD)
• Depression.
• Smoking cessation.
• Insomnia.

• L-tryptophan is an essential amino acid that is converted by the body to 5–hydroxytryptophan (5–HTP) and then to serotonin. Both L-tryptophan and 5–HTP cross the blood-brain barrier and have sedative effects. Depletion of endogenous tryptophan can cause a relapse in depression symptoms.

• Improved symptoms of depression.
• Improved sleep.

Absorption: Unknown.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-life: Unknown.

Contraindicated in:

• Hypersensitivity.
• Pregnancy and lactation.

Use Cautiously in:

• Eosinophilia.
• Kidney disease.
• Liver disease.

CNS: ataxia, headache, drowsiness, lightheadedness.

EENT: visual blurring.

GI: heartburn, abdominal pain, dry mouth, nausea.

Hemat: eosinophilia-myalgia syndrome.

Natural-Drug Products:

• Increased risk of serotonergic effects and serotonin syndrome with SSRIs, dextromethorphan, meperidine, tricyclic antidepressants monoamine oxidase inhibitors pentazocine and tramadol..
• Increased sedation with CNS depressants..

Natural-Natural Products:

• Additive sedation with herbs or supplements that have sedative properties such as kavaSt. John's wortvalerian5–HTPand others.
• Increased risk of serotonin syndrome with St. John's wort..

• PO (Adults): Insomnia — 1 gram 20 minutes before bedtime; Depression — 300 mg/day; Prementrual syndrome — 6 grams/day; Smoking cessation — 50 mg/kg/day.

• Capsules: Tablets: 500 mg;

• Assess sleep patterns prior to and periodically during therapy.
• Monitor for signs and symptoms of esosinophilia-myalgia sydrome (severe myalgia, arthralgia, intense eosinophilia) Less common symptoms include respiratory prodrome (cough, dyspnea, pulmonary infiltrates), limb edema, scleroderma, mononeuritis, evanescent skin rash, mild LFT elevations, and leukocytosis. If these symptoms occur, discontinue l-tryptophan.

• PO: Administer without regard to food.

• Instruct patient to take as directed; do not take more than directed.
• Advise patient to notify health care professional of symptoms of esosinophilia-myalgia sydrome occur.
• Advise female patient to notify health care professional if pregnancy is planned or suspected or if breastfeeding.

• Improvement in insomnia and premenstrual disorder.

tryptophan

• Deficient knowledge, Relate med (Patient/Family Teaching).

NDC Code^*

• 43857- BioActive Nutritional, Inc.
  • 43857-0232- Tryptophan
    • 43857-0232-1- 30 mL in 1 BOTTLE, DROPPER (43857-0232-1)

• 43857- BioActive Nutritional, Inc.
  • 43857-0416- Tryptophan
    • 43857-0416-1- 30 mL in 1 PACKAGE (43857-0416-1)